What is the recommended adult starting dosage of Guaifenesin (Expectorant) 100mg/5ml?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 23, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Adult Starting Dosage for Guaifenesin 100mg/5ml

The recommended adult starting dosage for guaifenesin 100mg/5ml is 200-400 mg (10-20 ml) every 4 hours, not to exceed 2400 mg (120 ml) in 24 hours.

Dosing Guidelines

Immediate-Release Formulation

  • Guaifenesin 100mg/5ml liquid should be dosed at 200-400 mg (10-20 ml) every 4 hours 1
  • Maximum daily dose should not exceed 2400 mg (120 ml) in 24 hours 1
  • Multiple daily doses are required to maintain therapeutic effect throughout the day due to guaifenesin's short half-life 1, 2

Extended-Release Formulation Alternative

  • If considering extended-release tablets instead of liquid, the dosage is 600-1200 mg every 12 hours 2
  • Extended-release formulation provides convenience with twice-daily dosing compared to the every 4-hour dosing of immediate-release formulations 2, 3

Clinical Considerations

Mechanism of Action

  • Guaifenesin acts by loosening mucus in the airways and making coughs more productive 1
  • It is indicated for relief of wet cough and chest congestion due to common cold and as an expectorant in stable chronic bronchitis 1

Safety Profile

  • Guaifenesin has a well-established and favorable safety profile in adult populations 1, 3
  • Most common adverse effects are mild and include gastrointestinal disturbances, nervous system effects, and skin reactions 3

Efficacy

  • Clinical efficacy has been demonstrated most widely in chronic respiratory conditions where excess mucus production and cough are more stable symptoms 1
  • Studies show guaifenesin inhibits cough-reflex sensitivity in acute viral cough 4

Important Precautions

  • Dose titration may be needed to achieve optimal therapeutic effect 1
  • Although rare, high doses of guaifenesin have been associated with central nervous system depression in overdose cases 5
  • For patients with persistent symptoms beyond 7 days, medical evaluation is recommended 3

Monitoring

  • No specific laboratory monitoring is required for guaifenesin therapy 1, 3
  • Assess clinical response to therapy, particularly improvement in productive cough and chest congestion 1

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.